oncgnostics GmbH Company
.png)
Oncgnostics develops IVD tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics.
Industry:
Biotechnology, Health Diagnostics, Medical, Robotics
Headquarters:
European Union (EU)
Founded Date:
2012-02-01
Employees Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Date:
2015
Last Funding Type:
Series A
Register and Claim Ownership